Reata Pharmaceuticals, Inc. ( NASDAQ:RETA – Get Rating ) insider Dawn Carter Bir sold 2,166 shares of the business's stock in a transaction that occurred on Friday, March 3rd. The stock was sold at an average price of $88.25, for a total value of $191,149.50. Following the sale, the insider now owns 48,509 shares of the company's stock, valued at $4,280,919.25. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link . Reata Pharmaceuticals Price Performance Reata Pharmaceuticals stock traded down $2.

https://www.dailypolitical.com/2023/03/06/dawn-carter-bir-sells-2166-shares-of-reata-pharmaceuticals-inc-nasdaqreta-stock.html

#dailypolitical